Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy

Surgery

Volumn 144, Issue 6, 2008, Pages 885-894

  Christante, Dara ^a   Pommier, SuEllen ^a   Givi, Babak ^a   Pommier, Rodney ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CISPLATIN; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; METRONIDAZOLE; MITOMYCIN C; OCTREOTIDE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATIC ARTERY; HUMAN; LIVER ABSCESS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE CANCER; NEUROENDOCRINE DISEASE; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL;

ADENOMA, ISLET CELL; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOID TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; DIGESTIVE SYSTEM NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 56449099034     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.08.037     Document Type: Article

References (22)

1. Moertel C.G. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 5 (1987) 1502-1522
2. Drougas J.G., Anthony L.B., Blair T.K., Lopez R.R., Wright Jr. J.K., Chapman W.C., et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 175 (1998) 408-412
3. Madoff D.C., Gupta S., Ahrar K., Murthy R., and Yao J.C. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17 (2006) 1235-1249 quiz 1250
4. Schnirer II, Yao J.C., and Ajani J.A. Carcinoid-a comprehensive review. Acta Oncol 42 (2003) 672-692
5. Ensminger W.D. Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29 (2002) 119-125
6. Moertel C.G., Johnson C.M., McKusick M.A., Martin Jr. J.K., Nagorney D.M., Kvols L.K., et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120 (1994) 302-309
7. Arnold R., Trautmann M.E., Creutzfeldt W., Benning R., Benning M., Neuhaus C., et al. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38 (1996) 430-438
8. Perez E.A., Koniaris L.G., Snell S.E., Gutierrez J.C., Sumner III W.E., Lee D.J., et al. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg 31 (2007) 1022-1030
9. O'Toole D., Hentic O., Corcos O., and Ruszniewski P. Chemotherapy for gastro-enteropancreatic endocrine tumours. Neuroendocrinology 80 Suppl 1 (2004) 79-84
10. Modlin I.M., Oberg K., Chung D.C., Jensen R.T., de Herder W.W., Thakker R.V., et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9 (2008) 61-72
11. Gupta S., Johnson M.M., Murthy R., Ahrar K., Wallace M.J., Madoff D.C., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104 (2005) 1590-1602
12. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 12 Suppl 2 (2001) S111-S114
13. Ruutiainen A.T., Soulen M.C., Tuite C.M., Clark T.W., Mondschein J.I., Stavropoulos S.W., et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18 (2007) 847-855
14. Strosberg J.R., Choi J., Cantor A.B., and Kvols L.K. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control 13 (2006) 72-78
15. Diaco D.S., Hajarizadeh H., Mueller C.R., Fletcher W.S., Pommier R.F., and Woltering E.A. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg 169 (1995) 523-528
16. Kress O., Wagner H.J., Wied M., Klose K.J., Arnold R., and Alfke H. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors-a retrospective single-center analysis. Digestion 68 (2003) 94-101
17. O'Toole D., and Ruszniewski P. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours. Best Pract Res Clin Gastroenterol 19 (2005) 585-594
18. Gupta S., Yao J.C., Ahrar K., Wallace M.J., Morello F.A., Madoff D.C., et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 9 (2003) 261-267
19. Osborne D.A., Zervos E.E., Strosberg J., Boe B.A., Malafa M., Rosemurgy A.S., et al. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 13 (2006) 572-581
20. Eriksson B.K., Larsson E.G., Skogseid B.M., Lofberg A.M., Lorelius L.E., and Oberg K.E. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83 (1998) 2293-2301
21. Givi B., Pommier S.J., Thompson A.K., Diggs B.S., and Pommier R.F. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery 140 (2006) 891-897 discussion 897-8
22. Turner G.B., Johnston B.T., McCance D.R., McGinty A., Watson R.G., Patterson C.C., et al. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut 55 (2006) 1586-1591